Funding Details
- Date Award
- May 13, 2024
- Vertical
- Biopharma
- Funding URL
- View Funding Page
Company Info
- Founders
- Vineeta Tripathi
- Company Description
- Vitarka Therapeutics is a pre-clinical stage biotech focused on developing RNAi therapies using a proprietary non-viral delivery platform. The underlying technology utilizes pore-forming proteins for targeted, cytosolic delivery of RNA therapeutics. Vitarka Therapeutics believes it can unlock new targeted therapeutic approaches for cancer treatment.
- Market
- Therapeutics
- Location
-
United Kingdom
Links